CORMORANT ASSET MANAGEMENT, LP Poseida Therapeutics, Inc. Transaction History

CORMORANT ASSET MANAGEMENT, LP portfolio value:

$6.53M
portfolio value

Poseida Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 1.85M shares 6.53M $3.53 1.85M